• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过序列分析预测HIV-1共受体的使用情况。

Predicting HIV-1 coreceptor usage with sequence analysis.

作者信息

Jensen Mark A, van 't Wout Angélique B

机构信息

Department of Microbiology, Box 358070, University of Washington School of Medicine, Seattle, WA 98195-8070, USA.

出版信息

AIDS Rev. 2003 Apr-Jun;5(2):104-12.

PMID:12876899
Abstract

Bioinformatics approaches are increasingly being used to identify and understand the genetic variation underlying changes in HIV-1 biological phenotype. The variable regions of the viral envelope are the major determinant of virus coreceptor usage and cell tropism. Specifically, amino acids 11 and 25 in the 3rd variable (V3) loop have been found to strongly influence viral syncytium inducing capacity and coreceptor usage. Many additional V3 loop changes, however, as well as changes elsewhere in Env, are thought to contribute to phenotype. In this review we describe several recently developed methods to analyze this variability and their use to predict biological phenotype based on sequence information. These approaches have identified changes in the V3 loop, in addition to the known changes at positions 11 and 25, that affect phenotype and significantly enhance our ability to predict phenotype from genotype. Besides improving phenotype prediction, methods that score V3 sequences on a continuous scale can also assist in the interpretation of evolutionary information about shifts in phenotype, and the relationship between that evolution and pathogenesis. Several examples and potential practical applications of this scoring are discussed. We conclude that advances in computational approaches have enhanced both our ability to predict and to understand HIV-1 biological phenotype evolution. Further development of these methods, by extending analysis to regions outside the V3 loop and to clades beyond subtype B, will extend our understanding of HIV-1 pathogenesis and inform treatment strategies.

摘要

生物信息学方法越来越多地用于识别和理解HIV-1生物学表型变化背后的基因变异。病毒包膜的可变区是病毒共受体使用和细胞嗜性的主要决定因素。具体而言,已发现第三个可变(V3)环中的第11和25位氨基酸对病毒诱导合胞体的能力和共受体使用有强烈影响。然而,许多其他V3环变化以及Env其他部位的变化也被认为对表型有贡献。在本综述中,我们描述了几种最近开发的分析这种变异性的方法,以及它们基于序列信息预测生物学表型的用途。这些方法除了确定了第11和25位已知变化外,还发现了V3环中影响表型的变化,并显著提高了我们从基因型预测表型的能力。除了改善表型预测外,以连续尺度对V3序列进行评分的方法还可以帮助解释有关表型转变的进化信息,以及这种进化与发病机制之间的关系。本文讨论了这种评分的几个例子和潜在的实际应用。我们得出结论,计算方法的进步增强了我们预测和理解HIV-1生物学表型进化的能力。通过将分析扩展到V3环以外的区域和B亚型以外的分支,进一步开发这些方法将扩展我们对HIV-1发病机制的理解,并为治疗策略提供信息。

相似文献

1
Predicting HIV-1 coreceptor usage with sequence analysis.通过序列分析预测HIV-1共受体的使用情况。
AIDS Rev. 2003 Apr-Jun;5(2):104-12.
2
[Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].[中国流行的HIV-1分离株的生物学特性与其env V3环序列变异性有关]
Zhonghua Yi Xue Za Zhi. 2004 Dec 2;84(23):1968-72.
3
Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1.人类免疫缺陷病毒1型原发性分离株的V3基因型、生物学表型、嗜性与共受体使用之间的关系。
J Hum Virol. 2001 Jul-Aug;4(4):179-87.
4
Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest.基于V3环序列的组合特征,利用随机森林改进对HIV-1共受体使用情况和表型的预测。
J Microbiol. 2007 Oct;45(5):441-6.
5
Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.评估八种不同的生物信息学工具以预测不同1型人类免疫缺陷病毒亚型中的病毒嗜性。
J Clin Microbiol. 2008 Mar;46(3):887-91. doi: 10.1128/JCM.01611-07. Epub 2008 Jan 16.
6
HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded coreceptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop.
Virus Res. 2009 Sep;144(1-2):306-14. doi: 10.1016/j.virusres.2009.04.020. Epub 2009 May 4.
7
Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.基于V3序列的基因型预测与HIV-1嗜性表型测定之间的相关性。
AIDS. 2008 Sep 12;22(14):F11-6. doi: 10.1097/QAD.0b013e32830ebcd4.
8
Indian primary HIV-2 isolates and relationship between V3 genotype, biological phenotype and coreceptor usage.印度原发性HIV-2分离株以及V3基因型、生物学表型与共受体使用之间的关系。
Virology. 2005 Jun 20;337(1):68-75. doi: 10.1016/j.virol.2005.04.008.
9
Genotypic analysis of human immunodeficiency virus type 1 env V3 loop sequences: bioinformatics prediction of coreceptor usage among 28 infected mother-infant pairs in a drug-naive population.1型人类免疫缺陷病毒env V3环序列的基因分型分析:初治人群中28对感染母婴共受体使用情况的生物信息学预测
AIDS Res Hum Retroviruses. 2011 Apr;27(4):411-9. doi: 10.1089/aid.2010.0142. Epub 2010 Oct 23.
10
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples.基于配对的外周血单个核细胞(PBMC)和血浆样本中V3环序列的HIV-1生物学表型及预测的共受体使用情况。
Virus Res. 2007 Dec;130(1-2):34-42. doi: 10.1016/j.virusres.2007.05.011. Epub 2007 Jun 19.

引用本文的文献

1
Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy.逃避体液免疫与接受长期抗逆转录病毒治疗的 HIV-1 感染患者的治疗失败有关。
Sci Rep. 2017 Jul 24;7(1):6222. doi: 10.1038/s41598-017-05594-5.
2
Evolution of coreceptor utilization to escape CCR5 antagonist therapy.共受体利用情况的演变以逃避CCR5拮抗剂治疗。
Virology. 2016 Jul;494:198-214. doi: 10.1016/j.virol.2016.04.010. Epub 2016 Apr 26.
3
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies.
趋化因子与趋化因子受体的结构及相互作用:对治疗策略的启示
Immunol Cell Biol. 2015 Apr;93(4):372-83. doi: 10.1038/icb.2015.15. Epub 2015 Feb 24.
4
Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.急性HIV-1感染患者中常用基因分型检测的性能及与HIV-1共受体嗜性表型检测的比较
J Antimicrob Chemother. 2015 May;70(5):1391-5. doi: 10.1093/jac/dku573. Epub 2015 Jan 20.
5
Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.确定利用CXCR4和CCR5的HIV-1共线性序列中的差异基因特征。
PLoS One. 2014 Sep 29;9(9):e107389. doi: 10.1371/journal.pone.0107389. eCollection 2014.
6
Bioinformatic analysis of HIV-1 entry and pathogenesis.HIV-1 进入与发病机制的生物信息学分析
Curr HIV Res. 2014;12(2):132-61. doi: 10.2174/1570162x12666140526121746.
7
HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.HIV-1 嗜性测试和 CCR5 拮抗剂的临床管理:魁北克审查和建议。
Can J Infect Dis Med Microbiol. 2013 Winter;24(4):202-8. doi: 10.1155/2013/982759.
8
Dual-acting stapled peptides target both HIV-1 entry and assembly.双重作用的订书钉肽靶向 HIV-1 进入和组装。
Retrovirology. 2013 Nov 15;10:136. doi: 10.1186/1742-4690-10-136.
9
Adhesion and fusion efficiencies of human immunodeficiency virus type 1 (HIV-1) surface proteins.人类免疫缺陷病毒 1 型(HIV-1)表面蛋白的黏附与融合效率。
Sci Rep. 2013 Oct 22;3:3014. doi: 10.1038/srep03014.
10
Arginine insertion and loss of N-linked glycosylation site in HIV-1 envelope V3 region confer CXCR4-tropism.HIV-1 包膜 V3 区的精氨酸插入和 N-连接糖基化位点缺失赋予了 CXCR4 嗜性。
Sci Rep. 2013;3:2389. doi: 10.1038/srep02389.